Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy
Rajesh K. Kasam(University of Cincinnati Medical Center), Satish K. Madala(University of Cincinnati Medical Center)
Cited by 33
Related Papers
Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis
|JCI Insight|2021|66
Wilms’ tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease
|JCI Insight|2018|60
Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis
|EMBO Molecular Medicine|2020|45
p70 ribosomal S6 kinase regulates subpleural fibrosis following transforming growth factor-α expression in the lung
|American Journal of Physiology-Lung Cellular and Molecular Physiology|2015|22
Interleukin 31 receptor α promotes smooth muscle cell contraction and airway hyperresponsiveness in asthma
|Nature Communications|2023|15